On Tuesday, Shares of Cemex SAB de CV (ADR) (NYSE:CX), lost -0.58% to $10.21.
CEMEX, declared noteworthy progress in its offer of products and solutions to support the construction of resilient and sustainable urban communities. The company offered urban solutions, building materials, services and expertise that met the most demanding standards of construction and sustainability performance.
During 2014, CEMEX evolved its sustainability approach to ensure its commitments are integrated in the business strategy and its daily activities around the world. The company has also created a Sustainability Committee reporting directly to the Board of Directors to guide its sustainability strategy and efforts.
CEMEX, S.A.B. de C.V., a building materials company, produces, markets, distributes, and sells cement, ready-mix concrete, aggregates, and other construction materials in Mexico, the United States, Northern Europe, the Mediterranean, South America, the Caribbean, and Asia.
Shares of Herbalife Ltd.(NYSE:HLF), inclined 7.49% to $51.25, during its last trading session.
Global nutrition company, Herbalife Ltd. (HLF), issued the following statement:
“Herbalife welcomes the decision by the U.S. District Court for the Central District of California to grant final approval of the class action settlement in the matter of Dana Bostick v. Herbalife International of America Inc et al.
As we have consistently stated, we believe that the settlement is fair, reasonable and adequate to class members, and we note the court found that the low number of claimants was not surprising in light of the substantial survey results indicating that most people join Herbalife to become discount consumers of our products.”
Herbalife Ltd., a nutrition company, develops and sells weight administration, healthy meals and snacks, sports and fitness, energy and targeted nutritional products, and personal care products. The company offers science-based products in four principal categories, counting weight administration; targeted nutrition; energy, sports, and fitness; and outer nutrition.
At the end of Tuesday’s trade, Shares of Starwood Hotels & Resorts Worldwide Inc (NYSE:HOT), gained 0.39% to $85.62.
W Hotels Worldwide, part of Starwood Hotels & Resorts Worldwide, Inc. (HOT), declared the completion of the highly anticipated $25 million renovation of W Los Angeles
West Beverly Hills, formerly known as W Los Angeles – Westwood. Nestled between the foothills of Beverly Hills and Bel-Air, while just minutes from Los Angeles’ Sunset Boulevard and the famed beaches of Santa Monica, the transformation, led by Dawson Design Associates, creates spaces where travelers can immerse themselves in a quintessential Los Angeles experience – hidden bungalows, fantastic service and innovative dining concepts. The top-to-bottom renovation also comprises a new destination restaurant, STK, through a partnership with The ONE Group which is planned to open this summer. STK will also provide an updated menu concept at WET®, the stunning and lushly landscaped ground-level pool featuring classic California-style cabanas, for the ultimate escape.
Starwood Hotels & Resorts Worldwide, Inc., together with its auxiliaries, operates as a hotel and leisure company worldwide. The company owns, operates, and franchises luxury and upscale full-service hotels, resorts, residences, retreats, select-service hotels, and extended stay hotels under the St. Regis, The Luxury Collection, W, Westin, Le Méridien, Sheraton, Four Points, Aloft, and Element brand names.
Finally, AmerisourceBergen Corp. (NYSE:ABC), ended its last trade with 1.59% gain, and closed at $115.11.
Asia Bio-Chem Group, declared its financial results for the three-month and fiscal year ending December 31, 2014.
Highlights
- With support from Beidahuang State Farm Group General Corp, during the fourth quarter, the Company resumed production and sales.
- Net loss for the fourth quarter was $36.4 million (-$0.43 per share) contrast with a net loss of $41.0 million (-$0.48 per share) during the fourth quarter of 2013.
- The company’s EBITDA improved to negative $23.2 million during the fourth quarter contrast with negative $34.3 million during the fourth quarter of 2013.
- The Company continues to fund its losses with loans from various sources. As at December 31, 2014 total loans outstanding were $248.1 million.
- The Company continues to enjoy the strong support of its banking group and successfully renewed $58.7 million in loans in the fourth quarter and obtained additional $41.7 million in new loans in the quarter.
- The Company maintains unrestricted cash balance of $7.5 million at December 31, 2014.
AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
